News Announcement

Aspira Pathlab & Diagnostics: Detailed Public Statement

06-Oct-2025 Download PDF Aspira Pathlab

Aftertrade Broking Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 13(4) 14(3) and 15(2) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011 and subsequent amendments thereof ("SEBI (SAST) Regulations 2011 ") for the attention of the Public Shareholders of Aspira Pathlab & Diagnostics Ltd ("Target Company").